Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Fundy13on Dec 11, 2018 1:19pm
114 Views
Post# 29098132

RE:Is the Therapix Deal good for FSD

RE:Is the Therapix Deal good for FSDI think the deal is very good for HUGE.  If they want to be a major player in medical they need to do somethign to move in that direction.  An idependent analysit valued TRPX at 84 million US, so getting an asset like that with a stock only transaction shoudl add value to HUGE.
Who knows what it will mean for SP in the short term, that is anyones guess, but it makes HUGE a much more legit company in the medical research space.
HUGE is in a great position to cover the expenses of continuing the research since they have no cost for the build out has that is being covered by XLY.  Should only be 1-1.5 years for FDA approvals and selling, assuming trials go well.
If HUGE does not buy TRPX then they are going to go shopping and likely issue shares to buy another company instead so share dilustion is going to happen regardless.
Bullboard Posts